The Italian Sunshine Act (Law No. 62/2022) mandates pharmaceutical, medical device, and other healthcare-related companies to publicly disclose financial relationships with healthcare professionals (HCPs) and healthcare organizations (HCOs). This initiative aims to enhance transparency and prevent corruption within the healthcare sector.
Recent Posts
- From Chaos to Compliance: How to Coordinate Multiple Departments for Italian Sunshine Act Reporting
- Dal caos alla compliance: come coordinare più dipartimenti per il reporting dell’Italian Sunshine Act
- Vector Health presenta il primo sistema di monitoraggio basato su AI per la compliance Sanità Trasparente in Italia
- Gli integratori alimentari: tra crescita e folle deregulation
- Vector Health Unveils First AI-Powered Monitoring System for Italian Sanità Trasparente Compliance